JP2022554094A5 - - Google Patents
Info
- Publication number
- JP2022554094A5 JP2022554094A5 JP2022523294A JP2022523294A JP2022554094A5 JP 2022554094 A5 JP2022554094 A5 JP 2022554094A5 JP 2022523294 A JP2022523294 A JP 2022523294A JP 2022523294 A JP2022523294 A JP 2022523294A JP 2022554094 A5 JP2022554094 A5 JP 2022554094A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyldiyl
- peg
- compound according
- amino
- thienoazepine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962926324P | 2019-10-25 | 2019-10-25 | |
| US62/926,324 | 2019-10-25 | ||
| PCT/US2020/057162 WO2021081402A1 (en) | 2019-10-25 | 2020-10-23 | Macromolecule-supported thienoazepine compounds, and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022554094A JP2022554094A (ja) | 2022-12-28 |
| JP2022554094A5 true JP2022554094A5 (enExample) | 2023-10-20 |
Family
ID=73476237
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022523294A Withdrawn JP2022554094A (ja) | 2019-10-25 | 2020-10-23 | 高分子支持チエノアゼピン化合物、及びそれらの使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230257393A1 (enExample) |
| EP (1) | EP4048314A1 (enExample) |
| JP (1) | JP2022554094A (enExample) |
| CN (1) | CN114828894A (enExample) |
| CA (1) | CA3154969A1 (enExample) |
| WO (1) | WO2021081402A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109843327B (zh) | 2016-07-07 | 2022-05-13 | 小利兰·斯坦福大学托管委员会 | 抗体佐剂缀合物 |
| WO2020190725A1 (en) | 2019-03-15 | 2020-09-24 | Bolt Biotherapeutics, Inc. | Immunoconjugates targeting her2 |
| TWI857167B (zh) | 2019-10-25 | 2024-10-01 | 美商博特生物治療公司 | 噻吩并氮呯免疫結合物及其用途 |
| IL300316A (en) * | 2020-08-13 | 2023-04-01 | Bolt Biotherapeutics Inc | Immune conjugates of pyrazolozapines and their uses |
| JP2024539993A (ja) | 2021-10-29 | 2024-10-31 | ボルト バイオセラピューティクス、インコーポレーテッド | システイン変異抗体を含むｔｌｒアゴニスト免疫複合体、及びその使用 |
| WO2026050214A1 (en) * | 2024-08-27 | 2026-03-05 | Bolt Biotherapeutics, Inc. | Anti-claudin, tlr agonist immunoconjugates and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20190336615A1 (en) * | 2017-01-27 | 2019-11-07 | Silverback Therapeutics, Inc. | Tumor targeting conjugates and methods of use thereof |
| CA3100544A1 (en) * | 2018-05-17 | 2019-11-21 | Bolt Biotherapeutics, Inc. | Immunoconjugates |
| TWI857167B (zh) * | 2019-10-25 | 2024-10-01 | 美商博特生物治療公司 | 噻吩并氮呯免疫結合物及其用途 |
-
2020
- 2020-10-23 EP EP20808564.7A patent/EP4048314A1/en not_active Withdrawn
- 2020-10-23 WO PCT/US2020/057162 patent/WO2021081402A1/en not_active Ceased
- 2020-10-23 JP JP2022523294A patent/JP2022554094A/ja not_active Withdrawn
- 2020-10-23 CN CN202080086885.5A patent/CN114828894A/zh active Pending
- 2020-10-23 CA CA3154969A patent/CA3154969A1/en active Pending
- 2020-10-23 US US17/768,165 patent/US20230257393A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022554094A5 (enExample) | ||
| JP2022553702A5 (enExample) | ||
| JP2022549510A5 (enExample) | ||
| JP2023524271A5 (enExample) | ||
| JP5548364B2 (ja) | レゾルシノール誘導体の高分子結合体 | |
| JP2022537158A5 (enExample) | ||
| JP5249016B2 (ja) | タキサン類の高分子結合体 | |
| JP5503872B2 (ja) | 核酸系代謝拮抗剤の高分子誘導体 | |
| JP5366940B2 (ja) | 葉酸若しくは葉酸誘導体の高分子結合体 | |
| JP5181347B2 (ja) | ポドフィロトキシン類の高分子結合体 | |
| JP5687899B2 (ja) | 生理活性物質の高分子結合体 | |
| JP2022546110A5 (enExample) | ||
| JP4877225B2 (ja) | ポリオキシアルキレン誘導体 | |
| JP5000512B2 (ja) | シチジン系代謝拮抗剤の高分子誘導体 | |
| JP2023171659A5 (enExample) | ||
| JP2022512643A5 (enExample) | ||
| JP2013528229A5 (enExample) | ||
| JP2013523896A5 (enExample) | ||
| JP2022533069A5 (enExample) | ||
| JP2011510120A (ja) | ポリオキサゾリン共重合体の多機能形態およびそれを含む薬物組成物 | |
| JP2024523453A5 (enExample) | ||
| JPWO2008010463A1 (ja) | コンブレタスタチン類の高分子結合体 | |
| JP5017107B2 (ja) | ポリペプチド等と反応し得る官能基を含むリビングラジカル重合開始剤、それを用いて得られる櫛形ポリマー、それから得られるポリペプチド複合体及び薬剤 | |
| JP2023553421A5 (ja) | 抗ｃｅａ免疫複合体、及びその使用 | |
| JP2024511088A5 (enExample) |